For more information on a faculty member, please click on a name to be redirected to a searchable database for the member's biography and research activities.
|
Bowden, |
Molecular mechanisms of physical and chemical carcinogenesis; cellular oncogene activation and differential gene expression during tumor progression |
|
Briehl, Vice Chair, CBIO GIDP |
Relationship between oxidative stress and disease processes, particularly cancer |
|
Chambers, |
Inhibition of CSF-1 and/or c-fms function; decrease bone metastasis from breast cancer and help alleviate bone pain |
|
Chen, |
Molecular mechanisms of oxidative stress and pharmacological agents of cytoprotection |
|
Cress, |
Regulation of normal and cancer cell responses to environmental signals |
|
Dieckmann, |
Organelle biogenesis |
|
Doetschman, |
TGFB in T-cell homeostasis and tolerance |
|
Dorr, |
Toxicology systems and mechanisms of action of cytotoxic anticancer agents; the pharmacology of cancer chemopreventive agents |
|
Fares, |
Membrane trafficking in C. elegans |
|
Futscher, |
Cancer epigenetics and epigenomics |
|
Gerner, |
Signaling pathways influencing growth and apoptosis in carcinogenesis; polyamine metabolism |
|
Ghosh, Sourav, PhD |
Regulation of cell polarity in development and disease |
|
Goodrum, Felicia, PhD |
Human cytomegalovirus (CMV) latency |
|
Gunatilaka, |
Natural products and medicinal chemistry including isolation, characterization and partial synthesis of anticancer agents and their mechanisms of action |
|
Hastings, Karen MD, PhD |
Antigen processing and immune recognition of melanoma |
|
Heimark, |
Molecular mechanisms of angiogenesis and prostate carcinoma epithelial-mesenchymal transformation; regulation of cadherins in vascular morphogenesis |
|
Hurley, |
Discovery and development of novel anticancer drugs; telomeres; telomerase; transcriptional control; topoisomerases as drug targets |
|
Ignatenko, |
Study of the molecular changes in gaA leading to malignancy for the purpose of identification of molecular markers for detection or prevention of gastrointestinal cancer |
|
Katsanis, |
Mechanisms of tumor-induced immunosuppression; promotion of anti-tumor immunity |
|
Kim, |
Cancer biology and tumor suppressors |
|
Landowski, Terry, PhD, Associate Professor, Medicine (Research) |
Molecular mechanisms of cell death and survival |
|
Larmonier, |
Mechanisms of tumor-induced immunosuppression; promotion of anti-tumor immunity |
|
Christine Laukaitis, MD, PhD, Assistant Professor, Clinical Medicine |
Gene copy number variation in cancer |
|
Limesand, |
Radiation-induced salivary gland dysfunction; mechanisms of damage, clinical prevention measures, and restoration therapies |
|
Martinez, Professor, Cellular and Molecular Medicine |
Mechanisms of colon cancer chemoprevention |
|
McDermott, Kimberly, PhD, Assistant Professor, Cellular and Molecular Medicine |
The role of cilia in mammary gland biology |
|
Meuillet, |
Regulation of PTEN in cancer cells; development of novel anti-cancer agents; modulation of receptor tyrosine kinases via membrane lipid and cholesterol content |
|
Montfort, |
Determine the atomic structures of proteins and seek to understand how protein structure gives rise to protein function - both in vitro and in living cells |
|
Nagle, |
Prostate cancer progression |
|
Nelson, |
Molecular mechanisms of physical and chemical carcinogenesis; biochemical and molecular pharmacology of cancer chemopreventive drugs |
|
Pagel, Mark "Marty", PhD, Associate Professor, Biomedical Engineering |
MRI methods to evaluate anti-cancer therapies; develop contrast agents for optical imaging and photoacoustic imaging. |
|
Porreca, Frank, PhD, Professor, Pharmacology |
Bone pain in cancer |
|
Rimsza, Lisa, MD, Professor, Pathology |
development of new molecular methods, including gene expression profiling in frozen and paraffin embedded tissues, for lymphoma diagnosis and prognosis |
|
Rogers, Greg, PhD, Assistant Professor, Cellular and Molecular Medicine |
characterizing a particular pathway (the Plk4 pathway) to control the biogenesis of centrosomes |
|
Romagnolo, |
Cellular and molecular mechanisms in mammary function; gene expression in cell proliferation and differentiation |
|
Schatz, Jonathan, MD, Assistant Professor, Medicine |
Lymphoma |
|
Schmelz, Monika, PhD |
Stem cells within the human prostate gland |
|
Schroeder, Joyce, PhD, Associate Professor, Molecular and Cellular Biology |
Breast cancer progression and invasion |
|
Smith, Catharine, PhD Associate Profesor, Pharmacology and Toxicology |
Epigenetic mechanisms of gene expression, particularly their regulation through signaling pathways and their modulation by anti-cancer drugs. |
|
Sun, Daekyu, PhD, Assistant Professor, Pharmacology |
Angiogenesis; understanding the chemical and biological mechanisms of the antineoplastic, DNA-damaging natural product leinamycin; understanding inducible resistant mechanisms in human cancer cells to DNA-damaging anticancer drugs |
|
Thompson Carino, |
Biomarker identification and validation for disease risk assessment and early detection; discovery of protein markers in nipple aspirate fluid |
|
Tran, Nhan, PhD Research Assistant Professor, UA Phoenix College of Medicine |
Development of therapeutic targets for invasive glioma cells: development of novel therapies. |
|
Weinert, |
Control of cell division in the yeast Saccharomyces cerevisiae; use of genetic, physiological and molecular techniques to study how the cell delays entry into mitosis if chromosomes are damaged |
|
Wilson, Jean, PhD, Professor, Cellular and Molecular Medicine |
Epithelial cells and neurons:regulation of development and polarity |
|
Wondrak, |
Development of novel molecular agents for skin cancer chemoprevention and chemotherapy |
|
Yang, |
Interaction of camptothecin anticancer drugs with DNA and topoisomerase I; Novel DNA quadruplex interacting compounds |
|
Assistant Professor, Molecular and Cell Biology |
Cancer pathways using quantitative systems biology |
|
Zhang, |
Nrf2/Keap1 signaling pathway |
E-mail this page